BB's Stock Haven

[dirkv]

today:
https://finance.yahoo.com/news/10-best-one-dollar-stocks-125218264.html

VIEWRAY INC 0,0718 -80,26%

9. ViewRay, Inc. (NASDAQ:VRAY)

Number of Hedge Fund Holders: 22

Shares of MRI-guided radiation therapy system company ViewRay, Inc. (NASDAQ:VRAY) has been struggling this year as the company pulled its guidance, posted disappointing quarterly figures and received analyst downgrades. Nonetheless, as of the end of the first quarter of this year, 22 hedge funds had stakes in ViewRay, Inc. (NASDAQ:VRAY), according to Insider Monkey’s proprietary database of 943 hedge funds and their holdings.

ViewRay, Inc. (NASDAQ:VRAY) earlier this year also revealed that it was considering strategic options, including a sale or merger. ViewRay, Inc. (NASDAQ:VRAY) also announced a cost reduction plan that would generate about $19 million to $23 million in cost savings annually.

Baron Discovery Fund made the following comment about ViewRay, Inc. (NASDAQ:VRAY) in its Q1 2023 investor letter:

“ViewRay, Inc. (NASDAQ:VRAY) sells equipment that enables MRI-guided radiation treatment of cancer. This equipment allows for real-time imaging of a patient’s tumor location and therefore accurate radiation delivery, even if the tumor moves during treatment. Shares declined on investor concerns around the company’s deposits at and loan commitments from Silicon Valley Bank. Our understanding is that the deposits are now secure and that ViewRay is in compliance with all debt covenants. Adoption of ViewRay’s equipment and MRI-guided radiation therapy has been accelerating on impressive early clinical trial results in pancreatic and prostate cancer and as patients have started “voting with their feet” and seeking treatment at centers with the capability to administer MRI-guided treatment. The company’s order book for new machines continues to accelerate. While supply-chain constraints may limit upside to 2023 installations, we still expect nearly 40% growth for the year and meaningfully higher sales in coming years.”